Divestiture

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

Perrigo takes a massive $1.3B impairment charge and plans a 7% workforce reduction as it pivots to a 'CORE' business amid a challenging outlook.

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

Crescent's record production and strategic acquisitions paint a complex picture for investors amid a significant earnings beat but a notable revenue miss.

Despite lithium market weakness, AMG Critical Materials' adjusted EBITDA surged 40%, showcasing the power of its diversified portfolio and a strategic pivot.

As Nicholas Bell heads to the Royal Ontario Museum, Melanie Kjorlien will steer Glenbow's landmark reopening and its pioneering free admission model.

A new economic study finds West Virginia's greyhound racing industry doesn't pay for itself, surviving on millions in subsidies with no net benefit to the state.

An anonymous tipster's courage led to an $11 million recovery from a government contractor, highlighting the IRS program that rewards those who expose tax cheats.

The sale of the 344-unit Esperanza at Duarte Station highlights strong demand for transit-oriented luxury living, even as the broader LA market cools.

With $400M in 2025 sales, Immunocore now leverages its KIMMTRAK success to fund a high-stakes pivot into broader cancers, HIV, and autoimmune disease.

NKT A/S posts record earnings and a €10B backlog, launching a new strategy and major investments to dominate the booming power cable market.

Posting sector-leading 6.5% organic growth, the testing and certification giant validates its LEAP | 28 strategy with strong profits and a new buyback.

Vow ASA reports record Q4 revenues but shifts strategy to focus on its booming maritime sector, following major write-downs in its industrial division.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

A report on 69,000 jobs shows Londoners outsource hedge trimming most. The real villain? Ladders, waste removal, and tight urban spaces.

A Florida jury found Publix 100% liable for a fall that led to three spinal surgeries for a young mother, rejecting the company's $600k offer.

Alloy producer Afarak's profits plummet despite rising revenue, revealing the harsh realities of currency woes, cheap imports, and a stalled market.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.